Do rural health disparities affect prevalence data in pediatric eosinophilic esophagitis?

TY - JOUR

T1 - Do rural health disparities affect prevalence data in pediatric eosinophilic esophagitis?

AU - CEGIR Investigator Group

AU - Sabet, Cameron

AU - Klion, Amy D.

AU - Bailey, Dominique

AU - Jensen, Elizabeth

AU - Chehade, Mirna

AU - Abonia, J. Pablo

AU - Rothenberg, Marc E.

AU - Furuta, Glenn T.

AU - Muir, Amanda B.

N1 - Funding Information: Conflicts of interest: M. E. Rothenberg is a consultant for Pulm One, Spoon Guru, ClostraBio, Serpin Pharm, Allakos, Celgene, AstraZeneca, Arena Pharmaceuticals, Ellodi Pharma, GlaxoSmithKline, Regeneron/Sanofi, Guidepoint, and Suvretta Capital Management, and has an equity interest in the first five listed, and royalties from reslizumab (Teva Pharmaceuticals), PEESSv2 (Mapi Research Trust), and UpToDate; and is an inventor of patents owned by Cincinnati Children's Hospital. G. T. Furuta is the chief medical officer of EnteroTrack. M. Chehade is a consultant for Regeneron, Allakos, Adare, Shire/Takeda, AstraZeneca, Sanofi, and Bristol Myers Squibb and has research funding from Regeneron , Allakos , Shire , AstraZeneca , and Danone . The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Conflicts of interest: M. E. Rothenberg is a consultant for Pulm One, Spoon Guru, ClostraBio, Serpin Pharm, Allakos, Celgene, AstraZeneca, Arena Pharmaceuticals, Ellodi Pharma, GlaxoSmithKline, Regeneron/Sanofi, Guidepoint, and Suvretta Capital Management, and has an equity interest in the first five listed, and royalties from reslizumab (Teva Pharmaceuticals), PEESSv2 (Mapi Research Trust), and UpToDate; and is an inventor of patents owned by Cincinnati Children's Hospital. G. T. Furuta is the chief medical officer of EnteroTrack. M. Chehade is a consultant for Regeneron, Allakos, Adare, Shire/Takeda, AstraZeneca, Sanofi, and Bristol Myers Squibb and has research funding from Regeneron, Allakos, Shire, AstraZeneca, and Danone. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2021/6

Y1 - 2021/6

UR - https://www.scopus.com/pages/publications/85106935880

U2 - 10.1016/j.jaip.2021.03.027

DO - 10.1016/j.jaip.2021.03.027

M3 - Letter

C2 - 34112494

AN - SCOPUS:85106935880

SN - 2213-2198

VL - 9

SP - 2549

EP - 2551

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 6

ER -